Detection of left ventricular hypertrophy by the R-wave voltage in lead aVL: population-based study

Carregando...
Imagem de Miniatura
Citações na Scopus
14
Tipo de produção
article
Data de publicação
2013
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER HEIDELBERG
Autores
RODRIGUES, Sergio Lamego
ANGELO, Lilian Claudia Souza
BALDO, Marcelo Perim
DANTAS, Eduardo Miranda
BARCELOS, Alexandre Maulaz
MILL, Jose Geraldo
Citação
CLINICAL RESEARCH IN CARDIOLOGY, v.102, n.9, p.653-659, 2013
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
According to hypertension guidelines, the recommended electrocardiographic (ECG) diagnostic criteria for left ventricular hypertrophy (LVH) are the Sokolow-Lyon and Cornel voltage criteria, both with general acceptance by primary care physicians. However, it was recently reported that the R-wave voltage in lead aVL (RaVL) was as good as other more complicated and time-consuming ECG criteria to detect LVH in hypertensive patients. Therefore, our aim was to investigate if the ability of the RaVL to identify echocardiographic left ventricular hypertrophy (ECHO-LVH) could be translated to the general population, a more realistic assessment of its utility in a nonreferral setting. 682 participants (43.5 % males), aged between 27 and 72 years from the urban population of Vitoria, ES, Brazil, were enrolled. We investigated the association of ECHO-LVH (LV mass > 51 g/Ht(2.7)) with several ECG voltage measurements: Sokolow-Lyon and Cornel criteria, S-wave voltage in lead V3 (SV3) and RaVL. The RaVL showed the best positive correlation with LV mass indexed to Ht(2.7), superior to both Cornell and Sokolow-Lyon criteria and was not influenced by gender. Analysis of the ROC curves showed that the RaVL depicted a significant superior performance in relation to all the other measurements in the ability to detect ECHO-LVH. SV3 was not correlated with LV mass. Thus, it seems that most of Cornell's performance depends on its simplified version, that is, RaVL. We have shown that the simple and single assessment of RaVL presented a greater diagnostic ability in detecting ECHO-LVH in the general population, signaling its value mainly as a screening tool.
Palavras-chave
Echocardiography, Electrocardiography, Left ventricular hypertrophy
Referências
  1. Bacharova L, 2009, J ELECTROCARDIOL, V42, P593, DOI 10.1016/j.jelectrocard.2009.06.007
  2. CASALE PN, 1985, J AM COLL CARDIOL, V6, P572
  3. Casiglia E, 2008, EUR J EPIDEMIOL, V23, P261, DOI 10.1007/s10654-008-9234-6
  4. Chinitz JS, 2008, J ELECTROCARDIOL, V41, P281, DOI 10.1016/j.jelectrocard.2007.12.001
  5. Chobanian AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI 10.1001/jama.289.19.2560
  6. Colosimo AP, 2011, ARQ BRAS CARDIOL, V97, P225
  7. Cuspidi C, 2012, J HYPERTENS, V30, P884, DOI 10.1097/HJH.0b013e328353093d
  8. DESIMONE G, 1992, J AM COLL CARDIOL, V20, P1251
  9. de Simone G, 2005, AM J HYPERTENS, V18, P191, DOI 10.1016/j.amjhyper.2004.08.032
  10. DESIMONE G, 1995, HYPERTENSION, V26, P979
  11. de Sousa AGP, 2009, EUR J EPIDEMIOL, V24, P101, DOI 10.1007/s10654-009-9314-2
  12. DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X
  13. DUBOIS D, 1989, NUTRITION, V5, P303
  14. Gerdts E, 2008, EUR J ECHOCARDIOGR, V9, P809, DOI 10.1093/ejechocard/jen155
  15. Gosse P, 2012, J HYPERTENS, V30, P990, DOI 10.1097/HJH.0b013e3283524961
  16. HANLEY JA, 1982, RADIOLOGY, V143, P29
  17. Kohsaka S, 2005, AM HEART J, V149, P181, DOI 10.1016/j.ahj.2004.06.006
  18. Mancia G, 2007, J HYPERTENS, V25, P1105, DOI 10.1097/HJH.0b013e3281fc975a
  19. METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2
  20. NORMAN JE, 1995, J AM COLL CARDIOL, V26, P1022, DOI 10.1016/0735-1097(95)00269-5
  21. Pewsner D, 2007, BRIT MED J, V335, P711, DOI 10.1136/bmj.39276.636354.AE
  22. Pierdomenico SD, 2010, AM J HYPERTENS, V23, P876, DOI 10.1038/ajh.2010.80
  23. Rodrigues SL, 2009, INT J CARDIOL, V135, P323, DOI 10.1016/j.ijcard.2008.03.066
  24. Rodrigues SL, 2008, ARQ BRAS CARDIOL, V90, P46, DOI 10.1590/S0066-782X2008000100008
  25. Rodriguez-Padial L, 2012, J ELECTROCARDIOL, V45, P494, DOI 10.1016/j.jelectrocard.2012.06.003
  26. SAHN DJ, 1978, CIRCULATION, V58, P1072
  27. Salles GF, 2010, AM HEART J, V159, P833, DOI 10.1016/j.ahj.2010.02.012
  28. SCHACK JA, 1950, AM HEART J, V40, P696, DOI 10.1016/0002-8703(50)90200-6
  29. Schocken DD, 2012, J ELECTROCARDIOL, V45, P498, DOI 10.1016/j.jelectrocard.2012.06.022
  30. Sociedade Brasileira de Cardiologia SBC Sociedade Brasileira deHipertensao SBH Sociedade Brasileira de Nefrologia SBN, 2007, ARQ BRAS CARDIOL, V89, pe24
  31. SOKOLOW M, 1949, AM HEART J, V37, P161, DOI 10.1016/0002-8703(49)90562-1
  32. Sundstrom J, 2001, CIRCULATION, V103, P2346
  33. Verdecchia P, 2009, LANCET, V374, P525, DOI 10.1016/S0140-6736(09)61340-4
  34. Verdecchia P, 1998, J AM COLL CARDIOL, V31, P383, DOI 10.1016/S0735-1097(97)00493-2
  35. Verdecchia P, 2003, REV ESP CARDIOL, V56, P843, DOI 10.1157/13051609
  36. Verdecchia P, 2009, J HYPERTENS, V27, P1697, DOI 10.1097/HJH.0b013e32832c0031
  37. Williams B, 2004, J HUM HYPERTENS, V18, P139, DOI 10.1038/sj.jhh.1001683